Circulating tumor DNA (ctDNA) is tumor-derived fragmented DNA in the bloodstream that
has come from primary or metastatic cancer sites. Neoplasm-specific genetic and epigenetic …

Colorectal cancer is one of the commonest cancers detected as also amongst the most
common causes of cancer death. Survival has improved due to better disease …

Colorectal cancer (CRC) recurrence after surgical resection results in poor clinical
outcomes. Long noncoding RNAs (lncRNAs) are emerging new targets for mediating …

The aim of our study is to evaluate the clinical efficacy of durvalumab in patients with
microsatellite instability‐high/mismatch repair‐deficient (MSI‐H/dMMR) or polymerase …

Importance Including race and ethnicity as a predictor in clinical risk prediction algorithms
has received increased scrutiny, but there continues to be a lack of empirical studies …

More than 140,000 people in the United States are diagnosed annually with colorectal
cancer (CRC), and 5% to 40% of patients treated with curative intent develop a recurrence …

Background: Most recurrences of early-stage colorectal cancer detected with current
surveillance measures are widespread and incurable. Circulating tumor DNA (ctDNA) may …

Background The purpose of this study was to determine the association between race and
long-term cancer outcomes (recurrence and overall survival) within a population of US …

Evidence from previous studies suggests a protective effect of metformin in patients with
colorectal cancer (CRC). The aim of this study was to examine the associations between …

Abstract Background Cancer stem cells (CSCs) play a key role in tumor cell growth, drug
resistance, recurrence, and metastasis. Proanthocyanidins (PC) is widely existed in plants …